ACP
IMMU
Acuta Capital Partners’s Immunomedics Inc IMMU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-511,500
| Closed | -$43.5M | – | 59 |
|
|
2020
Q3 | $43.5M | Sell |
511,500
-33,500
| -6% | -$2.85M | 11.81% | 1 |
|
|
2020
Q2 | $19.3M | Buy |
+545,000
| New | +$19.3M | 5.58% | 2 |
|
|
2020
Q1 | – | Sell |
-150,000
| Closed | -$3.17M | – | 44 |
|
|
2019
Q4 | $3.17M | Buy |
+150,000
| New | +$3.17M | 0.79% | 27 |
|
|
2019
Q3 | – | Sell |
-225,000
| Closed | -$3.12M | – | 38 |
|
|
2019
Q2 | $3.12M | Sell |
225,000
-275,000
| -55% | -$3.81M | 1.11% | 23 |
|
|
2019
Q1 | $9.61M | Buy |
500,000
+100,000
| +25% | +$1.92M | 4.57% | 7 |
|
|
2018
Q4 | $5.71M | Sell |
400,000
-1,655,500
| -81% | -$23.6M | 4.35% | 7 |
|
|
2018
Q3 | $42.8M | Sell |
2,055,500
-2,694,500
| -57% | -$56.1M | 15.27% | 1 |
|
|
2018
Q2 | $112M | Sell |
4,750,000
-1,100,000
| -19% | -$26M | 20.01% | 1 |
|
|
2018
Q1 | $85.5M | Sell |
5,850,000
-900,000
| -13% | -$13.1M | 13.96% | 1 |
|
|
2017
Q4 | $109M | Buy |
6,750,000
+12,294
| +0.2% | +$199K | 20.59% | 1 |
|
|
2017
Q3 | $94.2M | Buy |
6,737,706
+5,137,706
| +321% | +$71.8M | 16.88% | 1 |
|
|
2017
Q2 | $14.1M | Buy |
1,600,000
+1,097,000
| +218% | +$9.69M | 3.95% | 7 |
|
|
2017
Q1 | $3.25M | Sell |
503,000
-4,197,000
| -89% | -$27.2M | 0.77% | 27 |
|
|
2016
Q4 | $17.2M | Buy |
4,700,000
+850,000
| +22% | +$3.12M | 6.41% | 4 |
|
|
2016
Q3 | $12.5M | Sell |
3,850,000
-350,000
| -8% | -$1.14M | 4.7% | 4 |
|
|
2016
Q2 | $9.74M | Sell |
4,200,000
-1,326,172
| -24% | -$3.08M | 4.68% | 5 |
|
|
2016
Q1 | $13.8M | Buy |
5,526,172
+1,562,139
| +39% | +$3.91M | 7.73% | 3 |
|
|
2015
Q4 | $12.2M | Buy |
3,964,033
+2,252,966
| +132% | +$6.92M | 5.82% | 5 |
|
|
2015
Q3 | $2.94M | Buy |
+1,711,067
| New | +$2.94M | 1.7% | 21 |
|